Comparison of behavioural effects of NocII or NocIII, two related pronociceptin-derived peptides.
Prepronociceptin contains, in addition to nociceptin, other potentially excisable peptides which may have physiological significance. We have here considered NocII, a heptadecapeptide whose sequence lies immediately downstream of that of nociceptin in the precursor polypeptide, as well as NocIII which corresponds to NocII extended by a stretch of three arginine residues. When i.c.v.-administered in mice, NocII (10-10,000 ng) stimulated horizontal locomotor activity and decreased the latency to paw licking but neither to rearing nor escape jumping in the hot plate test (55 degrees C). When nociceptin (100 ng) and NocII (100 ng) were simultaneously intracerebroventricularly injected, each peptide produced its own effect without modifying the effect of the other. NocII was ineffective in the tail flick and writhing tests. NocIII (NocII-Arg-Arg-Arg) was inactive in all tests, even when assayed as long as 40 min following i.c.v. administration. The fact that NocII, but not its very close structural analogue NocII, is biologically active indicates that their may exist a specific receptor to NocII.
Florin
S
S
Unité de Neuropsychopharmacologie expérimentale (CNRS-UPRESA 6036), Faculté de Médecine et Pharmacie de Rouen, Saint Etienne du Rouvray, France.
Leblond
F
F
Suaudeau
C
C
Meunier
J C
JC
Costentin
J
J
D000595:Amino Acid Sequence; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature; D005106:Exploratory Behavior / Q000187:drug effects; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D009043:Motor Activity / Q000187:drug effects; D009479:Neuropeptides / Q000737:chemistry / Q000494:pharmacology*; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology; D018847:Opioid Peptides / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D010147:Pain Measurement; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D000097629:Nociceptin
D009479:Neuropeptides; D018847:Opioid Peptides; D014665:Vasodilator Agents; D000097629:Nociceptin; C106428:NocII neuropeptide; C402934:NocIII neuropeptide